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Abstract 
 
Galectins play an important role in inflammation, immunity, cancer progression and are 
potential targets for novel anti-cancer and anti-inflammatory compounds. Coumarin 
thiodigalacoside hydrid had proved to be potent, nanomolar, and selective inhibitor of 
galectin-3. Three novel coumarin thiodigalactoside derivatives have been synthesized by 
copper-catalyzed multicomponent reaction. Two compounds exhibited better inhibition than 
an earlier coumarin thiodigalactoside hybrid and possessed potentially useful fluorescence 
properties. 
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1. Introduction 
 
1.1 Coumarins 
 
Coumarins are widely abundant in nature and used in many applications such as medicine, 
fluorescent indicators, dyes in laser technology and perfumery
[1]
. In medicine, coumarins have 
shown activities against fungal, cancer and HIV. Iminocoumarins had been reported to be 
potential protein tyrosine kinase (PTK) inhibitors, therefore attractive target for the treatment 
of diseases involving excess cell proliferation and antitumor processes.  
 
1.2 Galectins 
 
Galectins are a family of lectins defined by having specific binding affinity for β-
galactosides
[2][3]
. In a wide range of biological mechanisms, galectins have an important role. 
Examples of mechanisms that are regulated by galectin activities are intracellular trafficking, 
cell signaling, apoptosis and cell adhesion. These functions are closely related to 
inflammation, immunity, and cancer progression. Galectins are widely spread throughout the 
nature in plants, vertebrates, invertebrates and even in sponges and fungi. They are 
synthesized in the cytosol and can reach the extracellular space or lumen of vesicles by a non-
classical secretory pathway. A characteristic feature of galectins which is connected with the 
biological activities is multiple carbohydrate recognition domains (CRD). CRD allows 
galectins to cross-link their glycoprotein ligands. There are three ways for galectins to cross-
link which are dependent on structural features. Prototype galectins which have one CRD 
within their polypeptide chain to form non-covalent dimers. Tandem-repeat galectins have 
two CRD within their polypeptide chain. Chimera galectin and the only one is galectin-3, 
carries a proline-rich collagen-like N-terminal linked to a C-terminal CRD. All these 
observations have led to the hypothesis that galectins are potential targets for novel anti-
cancer and anti-inflammatory compounds. 
 
1.3 Goal of project  
 
The aim of this project was to synthesize galectin-3 ligands, hydroxycoumarin 
(umbelliferone) thiodigalactoside hybrid and other coumarin thiodigalactoside hybrids and to 
test if these compounds are both fluorescent and better inhibitors than unsubstituted coumarin 
thiodigalactoside hybrid earlier synthesized in the research group. 
 
1.4 Competetive fluorescence polarization assay 
 
To evaluate the inhibition of galectin-3 a fluorescence polarization assay
[4]
 was used. In this 
method a fluorescent probe is excited with plane-polarized light and the degree of polarization 
remaining in the emitted light is measured. The remaining polarization decreases in relation to 
how much the fluorescent probe moves during the excited state. When the probe is bound to 
the protein it rotates slower than when free. From this measurement Kd values can be 
calculated.  
 
2. Results and discussion 
 
4-Methoxyphenyl β-D-galactopyranoside 3 was synthesized from D-galactose[5] (scheme 1). 
The first reaction was acetylation or esterification of D-galactose to form 1 and the yield was 
low, 36 %. After pouring the reaction solution on crushed ice, it was put in the fridge for three 
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nights. In water, acetic acid was formed and hydrolyzed the acetates and acid-catalyzed ester 
hydrolysis is reversible, but all product was not hydrolyzed. The solid had a brown color 
instead of white because the reaction was heated for too long time. But the product was pure 
according to 
1
H-NMR. Next step was to transform the acetate at C1 to 4-methoxyphenyl to 
yield 2. The reaction was done several times, sometime 1.5 equivalent boron trifluoride 
etherate was enough to complete the reaction. Other time the reaction was started with 1.5 
equivalents and 1 more equivalent was added to complete reaction. The product and starting 
material had the same Rf in TLC and the reaction was analyzed by MS to see if completed. 3 
was synthesized by deacetylation of 2 in base-catalyzed hydrolysis, which was irreversible. 
Sodium methoxide was used as a base and the reaction was stopped by ion-exchange resin.  
 
Scheme 1. Synthesis of 4-Methoxyphenyl β-D-galactopyranoside from D-galactose 
 
Propargylation of 3 afforded product 4 (scheme 2). Two different procedures for the reaction 
were done, one by Zhang
[6]
 and the other by Pera
[7]
. In the first article, toluene was used as 
solvent and 1.2 equivalent propargyl bromide. After stirring overnight at 60 °C, there was 
more starting material than product according to TLC. In the second paper, 1,4-dioxane was 
used as solvent and 5 equivalent propargyl bromide. After refluxing for 4.5 h the reaction was 
completed. The faster reaction may be due to higher temperature, the boiling point of 1,4-
dioxane was 101 °C, and more reagent. Also the solubility of the reagents was different 
because toluene was not as polar as 1,4-dioxane. 4 was then acetylated in mild conditions to 
give 5, scheme 2.  
 
Scheme 2. Synthesis of 4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-propargyl-β-D-galactopyranoside 
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p-Toluenesulfonyl azide
[8]
 (scheme 3) was synthesized and used as reagent in the synthesis of 
iminocoumarins via copper-catalyzed multicomponent reaction, MCR. 
 
 
Scheme 3. Synthesis of p-Toluenesulfonyl azide 
 
6a, 6b and 6c (scheme 4) were synthesized by MCRs
[1]
. In the synthesis of 6a, 2,4-
dihydroxybenzaldehyde was used and the product was difficult to purify. When DCM/MeOH 
was used in column chromatography, 2,4-dihydroxybenzaldehyde was co-eluted with the 
product. The impurities had to be eluted with EtOAc/Hep first, to elute the product 
DCM/MeOH had to be used. 6b was synthesized easier than 6a, because 6b was a less polar 
compound than 6a and EtOAc/Hep could be used to elute the product. In the synthesis of 6c, 
the product was not formed after stirring the reaction overnight as for 6a and 6b. According to 
TLC, the starting material was the major spot, but there was a slower moving spot. It was 
purified and analyzed, according to MS and 
1
H-NMR, the slower moving spot was the 
uncyclized molecule. For this reaction, 4-(diethylamino)salicylaldehyde was used. The 
electron pair of the nitrogen could be donated which would make the carbonyl carbon less 
electrophilic.  
 
Scheme 4. General procedure for synthesis of 3-O-iminocoumarin 
 
Scheme 5 showed the postulated mechanism for formation of iminocoumarins
[9]
. The 
intramolecular nucleophilic addition of the anionic intermediate E was one of critical steps for 
the domino process. The reaction towards 6c was done again, but this time the reaction was 
stirred for six days.  TLC showed no starting material left and the slower moving spot was 
much stronger than first time. It was purified and analyzed by MS and 
1
H-NMR and it was the 
product in 71 %. The uncyclized molecule and the product had the same Rf. The reaction may 
have been completed earlier because the reaction was not followed day by day.  
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A reaction with 2,3,6,7-Tetrahydro-8-
hydroxy-1H,5H-benzo[ij]quinolizine-9-
carboxaldehyde was tried, but the reaction 
did not work. The reaction was only stirred 
overnight, if the reaction was stirred for 
longer time it may had worked, because this 
reagent should have similar properties as 4-
(diethylamino)salicylaldehyde. A reaction 
using 2,5-dihydroxybenzaldehyde was 
done. The reaction was analyzed by MS and 
TLC, but the product was not purified. Next 
step was to remove the protective groups of 
6a by using sodium methoxide, but the 
reaction did not work. Under basic 
condition the hydroxyl could be 
deprotonated and elimination could occur. 
Deacetylation of 6b and 6c under basic 
conditions worked. The deacetylated 
product of 6b was not purified, but 
confirmed by MS and impure 
1
H-NMR. 
Deacetylation of 6c afforded 7c (scheme 6) 
and the pure product was isolated.  
 
 
Scheme 6. Deacetylation of 6c 
Instead of going further with monogalactoside, thiodigalactoside (tdg) was synthesized. 
Because tdg had shown similar binding mode and conformation as that in case of LacNAc. 
Attaching and fine-tuning aromatic amides to galactose C3 in LacNAc or tdg results in 
increase binding affinity of ligand against different galectins
[1]
. The synthesis of 9 was done in 
two steps (scheme 7) first step was conversion of 4-methoxyphenyl glycoside into 
corresponding glycosyl bromide
[10]
. Conversion of 5 afforded 8 in good yield. Next step was 
to convert 8 into 9
[1]
 and the yield was low. According to the procedure, catalytic amount of 
triethylamine should be enough. But 1 equivalent of triethylamine was needed for the reaction 
to finish.  
 
Scheme 5. Postulated Mechanism for Formation of 
Iminocoumarins
[9] 
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Scheme 7. Synthesis of 3,3’-di-propargyl substituted thiodigalactoside 
9
 
was used to synthesize 10a, 10b and 10c (figure 1). In the synthesis of 10a and 10c the 
reactions were not completed after stirring overnight as for monogalactoside. Instead 72 h 
were needed and the purification was difficult due to that impurities were moving close to the 
product. The reaction to synthesize 10b was cleaner because only one slower moving spot 
was observed.  
The reactions of tdg with aminosalicylaldehyde, 4-(diethylamino)salicylaldehyde and 2,3,6,7-
Tetrahydro-8-hydroxy-1H,5H-benzo[ij]quinolizine-9-carboxaldehyde, did not work. The 
reactions were stirred for seven days, heated at 50 °C for two days and even refluxed. But no 
product could be observed by MS and TLC. This problem may be solved by first synthesize 
iminocoumarin monogalactoside via MCR, and then do the thiodigalactoside coupling 
reaction. 
 
 
Figure 1. 3,3’-di-substituted  iminocoumarin thiodigalactosides 
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The final step was deacetylation of 10a, 10b and 10c to afford products 11a, 11b and 11c 
(figure 2). 10b was deacetylated with sodium methoxide. As mentioned before basic 
conditions did not work with compounds with base-sensitive groups. 10a and 10c were 
deacetylated by acetyl chloride in methanol
[11][12]
. When catalytic amount, 0.50 mol%, of 
acetyl chloride was used, the reactions did not go forward. Acetyl chloride had to be in 
excess, at least 100 equivalent was used and this may be due to imine was stable against acid. 
The reaction was slow and excess of reagent was used to push the reaction towards formation 
of the product. The reactions were stopped by evaporation at room temperature. Before 
evaporation only one spot was observed on TLC and after evaporation there were more spots. 
Which can be explained by that acid-catalyzed ester hydrolysis is reversible and therefore the 
low yields. Different methods for work-up were tried, but without success. The reactions were 
washed with saturated NaHCO3 solution and brine. Triethylamine and pyridine were used to 
neutralize the acid. Even ion-exchange resin, Amberlite IRA-400 (OH), was used but with no 
success. 
Because of the low yields alternative methods for deacetylation were tried, the first one was 
using dibutyltin oxide
[13]
. Deacetylation of 6b using dibutyltin oxide worked, the product was 
not purified, but instead compared with the MS and TLC of deacetylation of 6b with sodium 
methoxide. When the reaction was tried with 10c, it did not work. Another method was using 
methylamine in ethanol
[3][14]
, but with no success.  
 
 
Figure 2. 3,3’-di-substituted coumarin thiodigalactosides 
Compound 11 (figure 2) was synthesized by Mandal in the research group. Compounds 11, 
11a, 11b and 11c were purified by HPLC and evaluated in vitro as galectin-3 inhibitors in a 
fluorescence polarization assay
[4]
 (table 1). Compound 11 was used as reference to previous 
work and both 11a and 11c showed higher affinity. This may be due to additional hydrogen 
bonding at the binding site. The position of the hydroxyl in 11a may be more favorable than 
in 11c, therefore better inhibition. Compound 11b had the lowest affinity, it may be too bulky 
and wrong size for the binding site.  
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Table 1. Kd-values (µM) of 11, 11a, 11b and 11c against human galectin-3 measured by a fluorescence 
polarization assay
[4]
 
Compounds Galectin-3 
11 0.23±0.04 
11a 0.079±0.02 
11b 0.51±0.17 
11c 0.15±0.07 
       Figure 3. Umbelliferone 
The compounds were also analyzed by UV-Vis- and fluorescence spectrophotometer (figure 4 
and 5). From the UV-Vis and fluorescence measurements the absorption-, fluorescence 
intensity maximum, Stokes shift, normalized absorption and fluorescence intensity were 
determined for compounds 11, 11a, 11b and 11c. The absorption maximum, where the 
absorption was strongest, of 11a was the same as umbelliferone
[15]
 (figure 3), which meant 
that umbelliferyl was the absorbing moiety.  It was compared to umbelliferone because the 
structure of umbelliferyl on 11a was similar to umbelliferone and should therefore have 
similar fluorescence properties. The wavelength of absorption maximum, usually the same as 
excitation maximum, was used to determine the fluorescence intensity maximum. The 
fluorescence intensity maximum, where the fluorescence was strongest, is an important 
parameter in measurement of fluorescence lifetime. The lifetime indicates the average time 
the molecule stays in its excited state before emitting a photon and it is important in 
applications such as fluorescence resonance energy transfer and fluorescence-lifetime imaging 
microscopy
[16]
. Stokes shift (table 2) is the difference in wavelength between the maxima of 
the absorption and fluorescence intensity spectra. Stokes shift is important to determine how 
good a fluorophore is for fluorescence studies. It is easier to distinguish the light produced by 
emission from the light used for excitation with a large Stokes shift. The higher the 
fluorescence intensity is the larger numbers of photons are emitted and hence better 
fluorescence properties. To compare the fluorescence intensity, the normalized absorption and 
fluorescence intensity (figure 6) were calculated. The non-dashed lines are the absorbance and 
the dashed lines are the fluorescence intensity. In figure 4 one can see that compound 11a had 
two absorbance peaks, one at 325 nm and one above 400 nm. During the measurements, 11a 
was diluted many times because the fluorescence intensity was too high to be measured. 
When diluted only the peak at 325 nm was changing and 11a was normalized regarding to it. 
Compound 11a had the highest intensity and should be the most fluorescent compound. Also 
it was the only one that was fluorescent in the visible spectrum when dissolved in DMSO. 
 
 
Figure 4. Absorbance vs. wavelength determined by UV-Vis spectrophotometer 
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Figure 5. Fluorescence intensity vs. wavelength determined by fluorescence spectrophotometer 
Table 2. Absorption-, fluorescence intensity maximum and Stokes shift of 11, 11a, 11b and 11c 
Compounds     
  (nm)
a 
    
 
 (nm)
a Stokes shift (nm) 
11 278 - - 
11a 325 460 135 
11b 346 412 66 
11c 282 455 173 
a
Determined in DMSO 
 
Figure 6. Normalized absorbance and fluorescence intensity vs. wavelength, the non-dashed lines are the 
absorbance and the dashed lines are the fluorescence intensity 
 
3. Conclusions and future work 
 
Three carbohydrate coumarin hybrid molecules have been synthesized and tested against 
galectin-3. Two of the compounds show higher affinity than compound 11 and one compound 
shows lower affinity. It seems that having a hydroxyl group in the coumarin gives better 
inhibition and having a bulky group as in compound 11b gives worse inhibition. Larger 
amounts of compounds 11, 11a, 11b and 11c will need to be synthesized to determine which 
is the most fluorescence one. In overall most synthetic steps have been simple and given good 
yields except for deacetylation of hydroxy-iminocoumarins. An alternative method for 
deacetylation is needed and one way is to protect the hydroxyl with a silyl group which is 
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stable towards acid and bases. The acetates can easily be hydrolyzed by a base and the silyl 
group can be removed with fluoride salts. The reaction of monogalactoside with 
aminosalicylaldehyde did work, but did not work with tdg. What can be done is to introduce 
an electron withdrawing group either before or after MCR. It will be more difficult for the 
nitrogen to donate its electron pair. Another way is first synthesize iminocoumarin 
monogalactoside via MCR, and then do the thiodigalactoside coupling reaction. 
 
4. Experimental 
 
4.1 General methods 
 
All reagents and solvents were dried prior to use according to standard methods
[17]
. 
Commercial reagents were used without further purification unless otherwise stated. 
Analytical TLC was performed on silica gel 60-F254 (Merck) with detection by fluorescence 
and/or by charring following immersion in a 10 % sulfuric acid in ethanol solution. Column 
chromatography was performed with silica gel 40-60 µm, 60 Å. 
1
H NMR spectra were 
recorded on a Bruker Advance spectrometer at 400 MHz. 1-D and 2-D spectra are processed 
using Bruker Topspin software. NMR characterization data are represented using peak-
multiplicity abbreviations as s-singlet, d-doublet, t-triplet, q-quartet and m-multiplet. 
Coupling constants are given in Hertz (Hz). Low-resolution MS were obtained using ESI 
ionization. Absorption and fluorescent spectra were recorded on a Varian Cary-100 Bio UV-
Visible Spectrophotometer and Varian Cary Eclipse Fluorescence Spectrophotometer. 
 
4.2 Synthesis 
 
1,2,3,4,6-penta-O-acetyl-β-D-galactopyranoside (1) 
 
Acetic anhydride (400 ml, 4.26 mol) was added to sodium acetate (80 g, 0.98 mol) and the 
mixture was refluxed for 1 h. To the brown solution, but not clear, D-galactose (100 g, 0.56 
mol) was added in small portions. After addition the solution turned to a clear dark brown 
solution and heated for another hour. A precipitation was formed while cooling to room 
temperature. The thick slurry solution was poured on crushed ice and put in the fridge for 
three nights, filtered and washed with water (8 x 250 ml). Recrystallization with EtOH/H2O 
(2:1) afforded the product as a brown solid (90.9 g, 0.20 mol, 36 %). 
1
H NMR (400 MHz, 
CDCl3) δ: 5.71 (d, 1H, J  8.4 Hz, H-1), 5.43 (dd, 1H, J 0.8 Hz, 3.2 Hz, H-4), 5.36 (dd, 1H, J 
8.4 Hz, 10.4 Hz, H-2), 5.09 (dd, 1H, J  3.6 Hz, 10.4 Hz, H-3), 4.17 (m, 2H, H-6), 4.07 (t, 1H, 
J  0.8 Hz, H-5), 2.17 (s, 3H, OAc), 2.12 (s, 3H, OAc), 2.04 (s, 6H, 2xOAc), 1.99 (s, 3H, 
OAc). 
 
4-Methoxyphenyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside (2) 
 
(1) (44 g 0.11 mol) and 4-methoxyphenol (16.8 g, 0.14 mol) were dissolved in dry DCM (200 
ml) under nitrogen. The solution was cooled to 0 °C and boron trifluoride etherate (20.8 ml, 
0.17 mol) was added dropwise. The reaction was stirred at 0°C for 4 h and the reaction was 
stopped by adding water (200 ml). The organic phase was washed with water and saturated 
NaHCO3 solution. The organic phase was dried over MgSO4, filtered and removal of solvent 
left a brown solid (51 g, 0.11 mol, 99 %). 
1
H NMR (400 MHz, CDCl3) δ: 6.97 (d, 2H, J 8.8 
Hz, Ph), 6.83 (d, 2H, J 9.2 Hz, Ph), 5.48 (m, 2H, J 3.6 Hz, 8 Hz, 10.4 Hz, H-2, H-4), 5.11 (dd, 
1H, J 3.6 Hz, 10.4 Hz, H-3), 4.93 (d, 1H, J 8 Hz, H-1), 4.26 (m, 2H, H-6), 4.02 (t, 1H, H-5), 
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3.78 (s, 3H, OMe), 2.18 (s, 3H, OAc), 2.09 (s, 3H, OAc), 2.06 (s, 3H, OAc), 2.01 (s, 3H, 
OAc). LRMS (ESI) m/z: 477.1 [M+Na]
+
. 
 
4-Methoxyphenyl β-D-galactopyranoside (3) 
 
(2) (51 g, 0.11 mol) was dissolved in MeOH (600 ml) and 1M NaOMe solution was added 
until the reaction mixture was basic. The reaction was stirred for 20 h and stopped by 
Amberlyst 15. The solution was filtered and removal of solvent left a white/brown solid. The 
solid was washed with DCM. The product yield was 26.8 g (0.094 mol, 83 %). 
1
H NMR (400 
MHz, MeOD) δ: 7.09 (d, 2H, J 9.2 Hz, Ph), 6.85 (d, 2H, J 9.2 Hz, Ph), 4.74 (d, 1H, J 7.6 Hz, 
H-1), 3.90 (dd, 1H, J 0.8 Hz, 3.2 Hz, H-4), 3.79 (m, 3H, H-2, H-6), 3.75 (s, 3H, OMe), 3.66 
(t, 1H, J 0.8 Hz, H-5), 3.58 (dd, 1H, J 3.2 Hz, 9.6 Hz, H-3). LRMS (ESI) m/z: 309.1 [M+Na]
+
. 
 
 
4-Methoxyphenyl 3-O-propargyl-β-D-galactopyranoside (4) 
 
(3) (26.3 g, 0.092 mol) was dissolved in dry MeOH (750 ml) under nitrogen. Dibutyltin oxide 
(25.2 g, 0.10 mol) was added and the reaction was stirred at 75°C for 23 h. The dark brown 
solution was concentrated and the residue was dissolved in dry 1,4-dioxane (800 ml) under 
nitrogen. Tetrabutylammonium bromide (29.6 g, 0.092 mol) and propargyl bromide (49.5 ml, 
0.46 mol) were added and refluxed for 4.5 h. The solvent was concentrated and the residue 
was dissolved in MeOH and filtered. Removal of solvent left an dark brown oil and column 
chromatography, EtOAc/heptane (10:1), afforded pure product as a white/brown solid (18.2 g, 
0.056 mol, 61 %). 
1
H NMR (400 MHz, MeOD) δ: 7.07 (d, 2H, J 9.2 Hz, Ph), 6.84 (d, 2H, J 
9.2 Hz, Ph), 4.77 (d, 1H, J 8 Hz, H-1), 4.42 (t, 2H, J 2.4 Hz, OCH2), 4.13 (br d, 1H, J 3.2 Hz, 
H-4), 3.88 (dd, 1H, 8 Hz, 9.6 Hz, H-2), 3.78 (m, 5H, H-6, OMe), 3.64 (m, 2H, J 3.2 Hz, 9.6 
Hz, H-3, H-5), 2.88 (t, 1H, J 2.4 Hz, CH). LRMS (ESI) m/z: 347.1 [M+Na]
+
. 
 
4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-propargyl-β-D-galactopyranoside (5) 
 
(4) (13 g, 0.040 mol) was dissolved in 150 ml pyridine/acetic anhydride (2:1) under nitrogen. 
The reaction was stirred for 22 h and then diluted with EtOAc and washed with 1M HCl (3 x 
200 ml) and water (3 x 200 ml). The organic phase was dried over MgSO4 and filtered. 
Removal of solvent left an brown oil and column chromatography, EtOAc, afforded the 
product as a yellow solid (16.1 g, 0.036 mol, 90 %). 
1
H NMR (400 MHz, CDCl3) δ: 6.97 (d, 
2H, J 9.2 Hz, Ph), 6.82 (d, 2H, J 9.2 Hz, Ph), 5.45 (br d, 1H, J 2.4 Hz, H-4), 5.34 (dd, 1H, J 8 
Hz, 10 Hz, H-2), 4.92 (d, 1H, J 8 Hz), 4.22 (m, 4H, J 2.4 Hz, 6.4 Hz, H-6, OCH2), 3.96 (t, 1H, 
J 6 Hz, H-5), 3.90 (dd, 1H, J 3.6 Hz, 10 Hz, H-3), 2.45 (t, 1H, J 2.4 Hz, CH), 2.17 (s, 3H, 
OAc), 2.12 (s, 3H, OAc), 2.08 (s, 3H, OAc). LRMS (ESI) m/z: 473.3 [M+Na]
+
.  
 
p-Toluenesulfonyl azide 
 
p-Toluenesulfonyl chloride (20 g, 0.10 mol) was dissolved in acetone (200 ml) and cooled to 
0°C. Sodium azide (10.2 g, 0.16 mol) in water (100 ml) was added dropwise over 1h. The 
reaction was warmed to room temperature and stirred for 21 h. Acetone was removed under 
reduced pressure at 25°C and the reaction mixture was extracted with EtOAc (2 x 100 ml). 
The combined organic phases were washed with water (2 x 100 ml), 5 % Na2CO3 (2 x 100 
ml) and water (2 x 100 ml), dried over Na2SO4 and removal of solvent left a colorless liquid 
(15.9 g, 0.081 mol, 77 %). 
1
H NMR (400 MHz, CDCl3) δ: 7.86 (d, 2H, J 8.4 Hz, ArH), 7.42 
(d, 2H, J 8 Hz, ArH), 2.49 (s, 3H, Me). LRMS (ESI) m/z: 219.9 [M+Na]
+
. 
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4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-{[2-(p-Tolylsulfonyl-imino)-7-hydroxy-2H-
chromen-3-yl]-methyl}-β-D-galactopyranoside (6a) 
 
(5) (0.22 g, 0.49 mmol), 2,4-dihydroxybenzaldehyde (0.075 g, 0.54 mmol), CuI (9.4 mg, 
0.049 mmol) and p-Toluenesulfonyl azide (0.097 g, 0.49 mmol) were dissolved in dry THF 
(10 ml) under nitrogen and stirred for 1 h. Triethylamine (0.14 ml, 0.98 mmol) was added 
dropwise and stirred for 21 h. The solution was concentrated in vacuo and the residue was 
dissolved in DCM (10 ml) and washed with NH4Cl solution (2 x 30 ml) and brine (2 x 30 ml). 
The organic phase was dried over Na2SO4, filtered and concentrated. Column chromatography 
using EtOAc/heptane (1:1) to elute impurities and increasing polarity with MeOH to elute the 
product, afforded the product as a yellow solid (0.25 g, 0.34 mmol, 69 %). 
1
H NMR (400 
MHz, CDCl3) δ: 8.02 (d, 2H, J 8 Hz, SPh), 7.60 (s, 1H, ArH), 7.35 (d, 2H, J 8 Hz, ArH), 
7.31(d, 1H, J 8.4 Hz, SPh), 6.97 (d, 2H, J 9.2 Hz, Ph), 6.88 (d, 1H, J 2 Hz, ArH), 6.84 (m, 3H, 
J 9.2 Hz, Ph, ArH), 5.55 (br d, 1H, J 3.2 Hz, H-4), 5.42 (dd, 1H, J 8.4 Hz, 10.4 Hz, H-2), 4.86 
(d, 1H, J 8 Hz, H-1), 4.59, 4.39 (2d, 2H, J 15.2 Hz, CH2Ar), 4.27 (m, 2H, H-6), 3.92 (t, 1H, 
H-5), 3.78 (m, 4H, H-3, OMe), 2.40 (s, 3H, SPhMe), 2.16 (s, 3H, OAc), 2.10 (s, 3H, OAc), 
2.04 (s, 3H, OAc). LRMS (ESI) m/z: 762.0 [M+Na]
+
. 
 
4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-{[2-(p-Tolylsulfonyl-imino)-4,5-phenyl-2H-
chromen-3-yl]-methyl}-β-D-galactopyranoside (6b) 
 
(5) (50 mg, 0.11 mmol), 2-hydroxyl-1-naphthaldehyde (23 mg, 0.13 mmol), CuI (2 mg, 0.011 
mmol) and p-Toluenesulfonyl azide (26 mg, 0.13 mmol) were dissolved in dry THF (3 ml) 
under nitrogen and stirred for 1 h. Triethylamine (31 µl, 0.22 mmol) was added dropwise and 
stirred for 12 h. The solution was concentrated in vacuo and the residue was dissolved in 
DCM (10 ml) and washed with NH4Cl solution (2 x 10 ml) and brine (10 ml). The organic 
phase was dried over Na2SO4, filtered and concentrated. Column chromatography, 
EtOAc/heptane (1:1), afforded the product as a green solid (43 mg, 0.056 mmol, 50 %). 
1
H 
NMR (400 MHz, CDCl3) δ: 8.55 (s, 1H, ArH), 8.45 (d, 1H, J 8.4 Hz, ArH), 8.05 (d, 2H, J 8.4 
Hz, SPh), 8.02 (d, 1H, J 8.8 Hz ArH), 7.77  (t, 1H, J 7.2 Hz, ArH), 7.62 (t, 1H, J 7.2 Hz), 7.53 
(d, 1H, J 9.2 Hz, ArH), 7.34 (d, 2H, J 9.2 Hz, SPh), 6.99 (d, 2H, J 9.2 Hz, Ph) 6.84 (d, 2H, J 
8.8 Hz, Ph), 5.62 (br d, 1H, J 2.4 Hz, H-4), 5.53 (dd, 1H, J 8 Hz, 10 Hz, H-2), 4.92 (d, 1H, J 8 
Hz, H-1), 4.79, 4.49 (2d, 2H, J 15.2 Hz, CH2Ar), 4.30 (m, 2H, J 6.4 Hz, 6.8 Hz, H-6), 3.95 (t, 
1H, J 6.4 Hz, 6.8 Hz, H-5), 3.79 (m, 4H, J 3.2 Hz, H-3, OMe), 2.41 (s, 3H, SPhMe), 2.18 (s, 
3H, OAc), 2.11 (s, 3H, OAc), 2.09 (s, 3H, OAc). LRMS (ESI) m/z: 796.2 [M+Na]
+
. 
 
4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-{[2-(p-Tolylsulfonyl-imino)-7-diethylamino-2H-
chromen-3-yl]-methyl}-β-D-galactopyranoside (6c) 
 
(5) (0.60 g, 1.33 mmol), 4-(diethylamino)salicylaldehyde (0.31 g, 1.61 mmol), CuI (26 mg, 
0.14 mmol) and p-Toluenesulfonyl azide (0.32 g, 1.62 mmol) were dissolved in dry THF (10 
ml) under nitrogen and stirred for 1 h. Triethylamine (0.37 ml, 2.67 mmol) was added 
dropwise and stirred for 6 days. The solution was concentrated in vacuo and the residue was 
dissolved in DCM (20 ml) and washed with NH4Cl solution (2 x 40 ml) and brine (2 x 40 ml). 
The organic phase was dried over Na2SO4, filtered and concentrated. Column 
chromatography, EtOAc/heptane (2:1), afforded the product as a green/yellow solid (0.75 g, 
0.94 mmol, 71 %). 
1
H NMR (400 MHz, CDCl3) δ: 8.01 (d, 1H, J 8 Hz, SPh), 7.54 (s, 1H, 
ArH), 7.27 (m, 3H, SPh, ArH), 6.97 (d, 2H, J 9.2 Hz, Ph), 6.83 (d, 2H, J 9.2 Hz, Ph), 6.63 
(dd, 1H, J 2.4 Hz, 8.8 Hz, ArH), 6.47 (d, 1H, J 2 Hz, ArH), 5.54 (br d, 1H, J 2.8 Hz, H-4), 
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5.39 (dd, 1H, J 8.4 Hz, 10.4 Hz, H-2), 4.81 (d, 1H, J 8 Hz, H-1), 4.52, 4.41 (2d, 2H, J 14.4 
Hz, CH2Ar), 4.25 (m, 2H, J 6.4 Hz, 6.8 Hz, H-6), 3.87 (t, 1H, J 6.4 Hz, 6.8 Hz, H-5), 3.78 (m, 
4H, J 3.2 Hz, 9.2 Hz, H-3, OMe), 3.47 (q, 4H, J 6.8 Hz, 2xCH2N), 2.39 (s, 3H, SPhMe), 2.14 
(s, 3H, OAc), 2.09 (s, 3H, OAc), 2.02 (s, 3H, OAc), 1.24 (t, 6H, J 6.8 Hz, 2xCH3CH2N). 
LRMS (ESI) m/z: 817.2 [M+Na]
+
. 
 
4-Methoxyphenyl 3-O-(3-methylene-7-diethylamino-coumarin)-β-D-galactopyranoside 
(7c) 
 
MeOH (4 ml) was added to (6c) (50 mg, 0.063 mmol) and DCM was added dropwise until 
(10b) had dissolved. 1 M NaOMe solution was added until the solution was basic and stirred 
overnight. The reaction was stopped by Amberlite 15, filtered and concentrated. Column 
chromatography, EtOAc/Hep (4:1  8:1), afforded the product as a green/yellow solid (2 mg, 
0.0039 mmol, 6 %). 
1
H NMR (400 MHz, MeOD) δ: 7.98 (s, 1H, ArH), 7.42 (d, 1H, J 8.8 Hz, 
ArH), 7.08 (d, 2H, J 9.2 Hz, Ph), 6.85 (d, 2H, J 9.2 Hz, Ph), 6.75 (dd, 1H, J 2.4 Hz, 8.8 Hz, 
ArH), 6.55 (d, 1H, J 2.4 Hz, ArH), 4.79 (d, 1H, J 8 Hz, H-1), 4.67, 4.51 (2d, 2H, J 13.6 Hz, 
CH2Ar), 4.23 (br d, 1H, J 2.4 Hz, H-4), 3.92 (dd, 1H, J 7.6 Hz, 9.6 Hz, H-2), 3.81 (m, 2H, J 
6.8 Hz, H-6), 3.75 (s, 3H, OMe), 3.67 (t, 1H, J 6.8 Hz, H-5), 3.54 (m, 5H, J 3.2 Hz, 9.6 Hz, 
7.2 Hz, H-3, 2xCH2N), 1.23 (t, 6H, J 7.2 Hz, 2xCH3CH2N). LRMS (ESI) m/z: 538.2 
[M+Na]
+
. 
 
2,4,6-tri-O-acetyl-3-O-propargyl-α-D-galactopyranosyl bromide (8) 
 
(5) (4.78 g, 10.6 mmol) was dissolved in dry DCM (40 ml) under nitrogen. ZnBr2 (0.12 g, 
0.53 mmol) and AcBr (2.36 ml, 31.8 mmol) were added and stirred for 22 h. The reaction was 
diluted with DCM (50 ml) and washed with saturated NaHCO3 solution (150 ml) and brine 
(150 ml). The organic phase was dried over Na2SO4, filtered and concentrated. Column 
chromatography, EtOAc/heptane (1:5  1:1), afforded the product as an yellow oil (3.86 g, 
9.48 mmol, 79 %). 
1
H NMR (400 MHz, CDCl3) δ: 6.69 (d, 1H, J 4 Hz, H-1), 5.54 (br d, 1H, J 
2 Hz, H-4), 4.96 (dd, 1H, J 4 Hz, 10 Hz, H-2), 4.43 (t, 1H, H-5), 4.25 (t, 2H, J 2.4 Hz,  
OCH2), 4.22 (m, 2H, H-3, H-6), 4.12 (dd, 1H, H-6), 2.51 (t, 1H, J 2.4 Hz, CH), 2.14 (s, 6H, 
2xOAc), 2.08 (s, 3H, OAc). LRMS (ESI) m/z: 429.0, 431.0 [M+Na]
+
. 
 
Di-(2,4,6-tri-O-acetyl-3-O-propargyl-β-D-galactopyranosyl)-sulfane (9) 
 
Half amount of (8) (1.98 g, 4.86 mmol) was dissolved in dry acetonitrile (30 ml) under 
nitrogen. Thiourea (0.37 g, 4.86 mmol) was added and refluxed for 4 h. The reaction was 
cooled to room temperature and the other half of (8) in dry acetonitrile (20 ml) was added. 
Triethylamine (0.68 ml, 4.86 mmol) was added and stirred for 24 h. The solvent was 
concentrated and column chromatography, EtOAc/heptane (1:1), afforded the product as a 
white solid (1.29 g, 1.88 mmol, 39 %). 
1
H NMR (400 MHz, CDCl3) δ: 5.45 (br d, 1H, J 2.4 
Hz, H-4), 5.11 (t. 1H, J 10 Hz, H-2), 4.82 (d, 1H, J 10 Hz, H-1), 4.20 (m, 4H, H-6, OCH2), 
3.86 (m, 2H, H-3, H-5), 2.45 (t, 1H, J 2.4 Hz, CH), 2.15 (s, 3H, OAc), 2.10 (s, 3H, OAc), 2.08 
(s, 3H, OAc). LRMS (ESI) m/z: 709.1 [M+Na]
+
. 
 
Di-(2,4,6-tri-O-acetyl-3-O-{[2-(p-Tolylsulfonyl-imino)-7-hydroxy-2H-chromen-3-yl]-
methyl}-β-D-galactopyranosyl)-sulfane (10a) 
 
(9) (50 mg, 0.073 mmol), 2,4-dihydroxybenzaldehyde (24 mg, 0.18 mmol), CuI  (3 mg, 0.015 
mmol) and p-Toluenesulfonyl azide (35 mg, 0.18 mmol) were dissolved in dry THF (3 ml) 
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under nitrogen and stirred for 1 h. Triethylamine (41 µl, 0.29 mmol) was added dropwise and 
stirred for 72 h. The solution was concentrated in vacuo and the residue was dissolved in 
DCM (10 ml) and washed with NH4Cl solution (2 x 10 ml) and brine (10 ml). The organic 
phase was dried over Na2SO4, filtered and concentrated. Column chromatography, 
EtOAc/heptane (2:1)  DCM/MeOH (20:1), afforded the product as a yellow solid (45 mg, 
0.036 mmol, 49 %). 
1
H NMR (400 MHz, CDCl3) δ: 8.02 (d, 2H, J 8 Hz, SPh), 7.56 (s, 1H, 
ArH), 7.37 (d, 2H, J 8 Hz, SPh), 7.32 (d, 1H, J 10.8 Hz, ArH), 6.86 (d, 1H, J 2 Hz, ArH), 6.81 
(dd, 1H, J 2 Hz, 10.8 Hz, ArH), 5.58 (d, 1H, J 3.2 Hz, H-4), 5.18 (t, 1H, J 9.6 Hz, 10 Hz, H-
2), 4.82 (d, 1H, J 10 Hz, H-1), 4.57, 4.40 (2d, 2H, J 14 Hz, CH2Ar), 4.23 (m, 2H, J 6.8 Hz, 
7.2 Hz, H-6), 3.87 (t, 1H, , J 6.8 Hz, 7.2 Hz, H-5), 3.77 (dd, 1H, J 3.2 Hz, 9.6 Hz, H-3), 2.42 
(s, 3H, SPhMe), 2.14 (s, 3H, OAc), 2.10 (s, 3H, OAc), 1.98 (s, 3H, OAc). LRMS (ESI) m/z: 
1287.0 [M+Na]
+
. 
 
Di-(2,4,6-tri-O-acetyl-3-O-{[2-(p-Tolylsulfonyl-imino)-4,5-phenyl-2H-chromen-3-yl]-
methyl}-β-D-galactopyranosyl)-sulfane (10b) 
 
(9) (30 mg, 0.044 mmol), 2-Hydroxy-1-naphthaldehyde (18 mg, 0.11 mmol), CuI  (1.7 mg, 
mmol, 0.009 mmol) and p-Toluenesulfonyl azide (21 mg, 0.011 mmol) were dissolved in dry 
THF (3 ml) under nitrogen and stirred for 1 h. Triethylamine (24 µl, 0.18 mmol) was added 
dropwise and stirred for 17 h. The solution was concentrated in vacuo and the residue was 
dissolved in DCM (10 ml) and washed with NH4Cl solution (2 x 10 ml) and brine (10 ml). 
The organic phase was dried over Na2SO4, filtered and concentrated. Column 
chromatography, EtOAc/heptane (2:1), afforded the product as a green solid (23 mg, 0.017 
mmol, 39 %). 
1
H NMR (400 MHz, CDCl3) δ: 8.53 (s, 1H, ArH), 8.44 (d, 1H, J 8.4 Hz, ArH), 
8.05 (d, 2H, J 8 Hz, SPh), 8.02 (d, 1H, J 9.2 Hz, ArH), 7.93 (d, 1H, J 7.6 Hz, ArH),  7.76 (t, 
1H, J 7.2 Hz, 8 Hz, ArH), 7.62 (t, 1H, J 7.2 Hz, ArH), 7.52 (d, 1H, J 9.2 Hz, ArH), 7.39 (d, 
2H, J 7.6 Hz, SPh), 5.65 (br d, 1H, J 3.2 Hz, H-4), 5.33 (t, 1H, J 9.6 Hz, 10 Hz, H-2), 4.86 (d, 
1H, J 10.4 Hz, H-1), 4.78, 4.49 (2d, 2H, J 13.6 Hz, CH2Ar), 4.25 (m, 2H, H-6), 3.90 (t, 1H, J 
6.8 Hz, H-5), 3.79 (dd, 1H, J 3.2 Hz, 9.6 Hz, H-3), 2.42 (s, 3H, SPhMe), 2.16 (s, 3H, OAc), 
2.12 (s, 3H, OAc), 1.99 (s, 3H, OAc). LRMS (ESI) m/z: 1355.2 [M+Na]
+
. 
 
Di-(2,4,6-tri-O-acetyl-3-O-{[2-(p-Tolylsulfonyl-imino)-6-hydroxy-2H-chromen-3-yl]-
methyl}-β-D-galactopyranosyl)-sulfane (10c) 
 
(9) (0.20 g, 0.29 mmol), 2,5-dihydroxybenzaldehyde (97 mg, 0.70 mmol), CuI  (11 mg, 0.058 
mmol) and p-Toluenesulfonyl azide (0.14 g, 0.70 mmol) were dissolved in dry THF (3 ml) 
under nitrogen and stirred for 1 h. Triethylamine (0.16 ml, 1.17 mmol) was added dropwise 
and stirred for 72 h. The solution was concentrated in vacuo and the residue was dissolved in 
DCM (10 ml) and washed with NH4Cl solution (2 x 10 ml) and brine (10 ml). The organic 
phase was dried over Na2SO4, filtered and concentrated. Column chromatography, 
DCM/MeOH (20:1), afforded the product as a yellow solid (0.13 g, 0.10 mmol, 34 %). 
1
H 
NMR (400 MHz, CDCl3) δ: 8.01 (d, 2H, J 8.4 Hz, SPh), 7.52 (s, 1H, ArH), 7.34 (d, 2H, J 8 
Hz, SPh), 7.19 (d, 1H, J 9.2 Hz, ArH), 7.01 (dd, 1H, J 3.2 Hz, 9.2 Hz, ArH), 6.84 (d, 1H, J 
3.2 Hz, ArH), 5.55 (br d, 1H, J 2.4 Hz, H-4), 5.21 (t, 1H, J 9.6 Hz, 10 Hz, H-2), 4.81 (d, 1H, J 
10 Hz, H-1), 4.61, 4.39 (2d, 2H, J 14.8 Hz, CH2Ar), 4.25 (m, 2H, J 6.4 Hz, 7.2 Hz, H-6), 3.88 
(t, 1H, J 6.8 Hz, 7.2 Hz, H-5), 3.76 (dd, 1H, J 3.2 Hz, 9.6 Hz, H-3), 2.41 (s, 3H, SPhMe), 2.14 
(s, 3H, OAc), 2.10 (s, 3H, OAc), 2.03 (s, 3H, OAc). LRMS (ESI) m/z: 1287.5 [M+Na]
+
. 
 
Di-(3-O-(3-methylene-7-hydroxy-coumarin)-β-D-galactopyranosyl)-sulfane (11a) 
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(10a) (25 mg, 0.020 mmol) was dissolved in MeOH/DCM (1:1) and AcCl (0.11 ml, 1.54 
mmol) was added slowly. The solution was stirred for 2 days and concentrated at room 
temperature. Column chromatography, DCM/MeOH (5:1), afforded the product as a white 
solid (2 mg, 0.0028 mmol, 14 %). 
1
H NMR (400 MHz, DMSO-d6) δ: 10.49 (s, 1H, HO-Ph), 
8.11 (s, 1H, ArH), 7.50 (d, 1H, J 8 Hz, ArH), 6.82 (dd, 1H, J 2.4 Hz, 8.4 Hz, ArH), 6.74 (d, 
1H, J 2 Hz, ArH), 5.20 (d, 1H, J 6 Hz, HO-2), 4.62 (m, 3H, H-1, HO-4, HO-6), 4.54 (2d, 2H, 
J 14.4 Hz, CH2Ar), 4.02 (br s, 1H, H-4), 3.60 (m, 3H, H-2, H-6), 3.39 (m, 2H, H-3, H-5). 
LRMS (ESI) m/z: 729.1 [M+Na]
+
. 
 
Di-(3-O-(3-methylene-4,5-phenyl-coumarin)-β-D-galactopyranosyl)-sulfane (11b) 
 
MeOH (10 ml) was added to (10b) (28 mg, 0.021 mmol) and DCM was added dropwise until 
(10b) had dissolved. 1 M NaOMe solution was added until the solution was basic and stirred 
for 2 h. Three drops of water was added and stirred overnight. The reaction was stopped by 
Amberlite 15, filtered and concentrated. Column chromatography, DCM/MeOH (10:1), 
afforded the product as a white solid (10 mg, 0.013 mmol, 61 %). 
1
H NMR (400 MHz, 
DMSO-d6) δ: 9.09 (s, 1H, ArH), 8.61 (d, 1H, J 8 Hz, ArH), 8.18 (d, 1H, J 8.8 Hz, ArH), 8.08 
(d, 1H, J 8 Hz, ArH), 7.79 (m, 1H, J 8 Hz, ArH), 7.65 (m, 1H, J 8 Hz, ArH), 7.62 (d, 1H, J 
8.8 Hz, ArH), 5.60 (d, 1H, J 5.6 Hz, HO-2), 4.79 (d, 1H, J 4.8 Hz, HO-4), 4.67 (m, 4H, H-1,  
CH2Ar, HO-6), 4.09 (br s, 1H, H-4), 3.76 (m, 1H, H-2), 3.58 (m, 2H, H-6), 3.47 (m, 2H, H-3, 
H-5). LRMS (ESI) m/z: 796.9 [M+Na]
+
. 
 
Di-(3-O-(3-methylene-6-hydroxy-coumarin)-β-D-galactopyranosyl)-sulfane (11c) 
 
(10c) (14 mg, 0.011 mmol) was dissolved in MeOH/DCM (1:1) and AcCl (0.16 ml, 2.21 
mmol) was added slowly. The solution was stirred for 6 days and concentrated at room 
temperature. Column chromatography, DCM/MeOH (5:1), afforded the product as a white 
solid (2 mg, 0.0028 mmol, 26 %). 
1
H NMR (400 MHz, DMSO-d6) δ: 9.73 (s, 1H, HO-Ph), 
8.14 (s, 1H, ArH), 7.27 (d, 1H, J 8.8 Hz, ArH), 7.02 (m, 2H, J 2.8 Hz, 8.8 Hz, ArH), 5.26 (d, 
1H, J 5.6 Hz, HO-2), 4.64 (m, 3H, H-1, HO-4, HO-6), 4.58 (2d, 2H, J 15.2 Hz, CH2Ar), 4.02 
(br s, 1H, H-4),  3.65 (m, 1H, H-2), 3.52 (m, 2H, H-6), 3.39 (m, 2H, H-3, H-5). LRMS (ESI) 
m/z: 729.2 [M+Na]
+
. 
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